Cite
HARVARD Citation
Ahluwalia, M. et al. (n.d.). ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma. Neuro-oncology. pp. vi10-vi11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ahluwalia, M. et al. (n.d.). ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma. Neuro-oncology. pp. vi10-vi11. [Online].